title: Question 1: Treatment of mild to moderate ketoacidosis in children and adolescents with subcutaneous insulin.
authors.affiliation: Diabeter, Center for Pediatric and Adolescent Diabetes Care and Research, Rotterdam, The Netherlands.
authors.forename: D
authors.initials: D
authors.lastname: Mul
authors.affiliation: HagaZiekenhuis/Juliana Children's Hospital, The Hague, The Netherlands.
authors.forename: Eva
authors.initials: E
authors.lastname: Molendijk
mesh_terms: D020155:3-Hydroxybutyric Acid / Q000097:blood; D000293:Adolescent; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D016883:Diabetic Ketoacidosis / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage* / Q000627:therapeutic use; D007332:Insulin Infusion Systems
chemical_list: D001786:Blood Glucose; D007328:Insulin; D020155:3-Hydroxybutyric Acid
keywords: Adolescent Health; Diabetes; Endocrinology; Evidence Based Medicine